“Resveratrol-mediated decrease in proliferation was reversed by cotreatment with ICI 182,780, and resveratrol effectively competed with 17β-estradiol for binding to the ER, exhibiting an IC50 of 8.92 ± 0.14 μM. Resveratrol induced a sustained increase in ER-dependent NO production.”